[CME] Texas Medical Cannabis Symposium | January 9, 2021

The Association of Cannabis Specialists (ACS) is hosting  the first Texas Medical Cannabis Symposium on January 9, 2021. Attendees will get a comprehensive overview of the medicine, science, and policy issues facing practitioners, with reference to current Texas policy. 

Presentations will be provided by some of the most notable experts and experienced cannabis specialists, including Mike Tagen Ph.D., Jordan Tishler M.D., Stacia Woodcock Pharm.D.,  Marcel Bonn-Miller, PhD and Julia Arnsten, M.D.

This CME activity provides 5 Category 1 AMA CME credits and is geared to  legislators, legislative staff members, legal professionals and clinicians in the medical cannabis space. Learn more.


Jan 9, 2021 7:45AM–8:45AM · Endocannabinoid System 101
Presented by Mike Tagen, Ph.D.
This presentation will discuss what is known about the function and structure of the endocannabinoid system and how it relates to human illness.

Jan 9, 2021 8:45AM–9:45AM · Medical Cannabis Overview
Presented by Jordan Tishler, M.D.
This presentation will discuss basics of therapeutics of human illness using cannabis and cannabinoids.

Jan 9, 2021 10:15AM–11:15AM · Cannabis Research
This presentation will discuss areas of future research needed for better understanding of risk/benefits of cannabis.

Jan 9, 2021 11:15AM–12:15PM · Science on Pain/Opioid Reduction
Presented by Julia Arnsten, M.D.

Jan 9, 2021 12:30PM–1:30PM · CBD Pharmacokinetics
Presented by Stacia Woodcock, PharmD
This presentation will discuss the interaction of CBD specifically with the human body and what risks/concerns that may present.

Jan 9, 2021 1:30PM–2:30PM · Medical Cannabis Policy Choices
Presented by Jordan Tishler, M.D.
This presentation will discuss needed legal and regulatory changes needed to better/adequately address the needs of clinicians as they provide care for patients.

About ACS

“The Association of Cannabis Specialists ensures the highest standards in the practice of cannabis medicine, safeguards patient care with clinical best practices, and interfaces with other stakeholders in the cannabis community. We believe that patients are uniquely vulnerable and have very different needs than recreational users. We provide evidence and experience-based education for patients, cannabis clinicians, referring clinicians, and lawmakers to help them understand cannabis medicine and make informed decisions. We are an advocacy organization striving to provide guidance on best practices in the laws and regulations at the federal, state, and international levels.”


This event is sponsored by one of our allied organizations, the Foundation for an Informed Texas.